4//SEC Filing
Kennedy Giulia C 4
Accession 0001384101-22-000113
CIK 0001384101other
Filed
Aug 8, 8:00 PM ET
Accepted
Aug 9, 5:16 PM ET
Size
22.9 KB
Accession
0001384101-22-000113
Insider Transaction Report
Form 4
VERACYTE, INC.VCYT
Kennedy Giulia C
Chief Scientific & Med Officer
Transactions
- Sale
Common Stock
2022-08-05$26.54/sh−1,028$27,283→ 70,032 total - Exercise/Conversion
Stock Option (right to buy)
2022-08-05−2→ 0 totalExercise: $10.45Exp: 2024-09-15→ Common Stock (2 underlying) - Award
Common Stock
2022-08-05+10,702→ 71,055 total - Exercise/Conversion
Common Stock
2022-08-05$6.45/sh+2$13→ 71,059 total - Exercise/Conversion
Common Stock
2022-08-05$10.45/sh+2$21→ 71,057 total - Exercise/Conversion
Common Stock
2022-08-05$5.43/sh+1$5→ 71,060 total - Award
Stock Option (right to buy)
2022-08-05+18,248→ 18,248 totalExercise: $27.90Exp: 2032-08-05→ Common Stock (18,248 underlying) - Exercise/Conversion
Stock Option (right to buy)
2022-08-05−2→ 0 totalExercise: $6.45Exp: 2026-02-28→ Common Stock (2 underlying) - Exercise/Conversion
Stock Option (right to buy)
2022-08-05−1→ 0 totalExercise: $5.43Exp: 2026-03-14→ Common Stock (1 underlying)
Footnotes (4)
- [F1]Restricted stock units awarded on August 5, 2022 vest 1/3rd on September 2, 2023 and 1/12th per quarter thereafter subject to continuing employment of the Reporting Person on each vesting date.
- [F2]The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 14, 2022.
- [F3]The option becomes exercisable as to 1/3rd of the shares on August 5, 2023, and the remaining shares vest at a rate of 1/36th of the total number of shares subject to the award for each month of continuous service thereafter.
- [F4]The option is fully vested.
Issuer
VERACYTE, INC.
CIK 0001384101
Entity typeother
Related Parties
1- filerCIK 0001769333
Filing Metadata
- Form type
- 4
- Filed
- Aug 8, 8:00 PM ET
- Accepted
- Aug 9, 5:16 PM ET
- Size
- 22.9 KB